{"name":"Txinno Bioscience Inc.","slug":"txinno-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9TWGhvcXg2N0lwYjZ4RVNKQmhCbTd3bTdJNzllLXpvcGxjUDRfQ3gtMVZHV04wZ1E1Vlk5NWlELTI5RHhtV0pMaUVTVXpWTHlIbWlYNE5SQjlvTVc0bGM5bEtxSEwzQkFadkw0bNIBcEFVX3lxTE1ZUGNnLXR0aU9mNW05V29OVTdibXBINHp4UVBSWjNaUlZvNGdMOHBhanF1NGFlOF9Rb2Etdjkwa1RwSHk4a1J3NE9hU1Vqc1NVVmlzaUs1bEg5ZjlWMGtRRENCWmp4MlBhSE9zSTJDZ2U?oc=5","date":"2026-03-31","type":"pipeline","source":"더바이오","summary":"Txinno Bioscience secures clinical PoC for ENPP1 inhibitor, expands into ULK1 PROTAC and molecular glues - 더바이오","headline":"Txinno Bioscience secures clinical PoC for ENPP1 inhibitor, expands into ULK1 PROTAC and molecular glues - 더바이오","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE96RWdDUnpFQS1BYndRQ0NLb2ItQWVsOHlDSDF4SmNrZUZpdTNVRmRKMEM2UDE1dGtYZXZ5em90cDFva29LS0lHcXlMR0ZJeG4xN0pzcEdMcl94Nkg1M3lIY0l6TktpdXh4bWhmS9IBcEFVX3lxTE1MeWJwVGFwOExFcEdCUWhLeGRENzYwdjlmWHVJSzZlanB1SEFBSTUzYTRYOXhpaF9DbmRoV0NPbXl3UG03TkxqZ3BXQ1ZIR0FNSm5YR1ZzaHZkc05BOU9GRkJhQlVINjlqdWpWUV9SNlQ?oc=5","date":"2026-03-30","type":"pipeline","source":"더바이오","summary":"[AACR] Txinno Bioscience set to unveil preclinical results for ‘ULK1 targeted protein degrader’ - 더바이오","headline":"[AACR] Txinno Bioscience set to unveil preclinical results for ‘ULK1 targeted protein degrader’ - 더바이오","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOclhZckRnUnJ0dl9fSGUtUk9WN2hITFVKbC04TjhYOGNoaUNPMlRxUElsaU8wTzBxNnF0ZG54MjY5LTJYTGRRdFF6YzBrTWZzWUE4aV9sMjdrZWZid0R6Q1dxU211OVJkcVh0bFBNM0duMVBTTjBTSmRzRFU0QlpSUdIBlAFBVV95cUxOR2oxT0tRSlo4ZkJVR2RtNFUtWXE2U2RUdUxpeXR5YkVNdnE5QTRWNmlLNlV1c1Y5czMwWXd1XzBNX3VTTkpvc1JYRm9XYlU0dFRDNmRTZTdRX2lKX29FV245TlhjNkdFRlRaQ1I2TE91Zl9WekQtNE03TDg4b0JPMHM5ck1xNldNVGg1MjdWZy00bmRu?oc=5","date":"2025-07-23","type":"pipeline","source":"Chosunbiz","summary":"Korean biotech firms attract major investments amid rising stock prices and government support - CHOSUNBIZ - Chosunbiz","headline":"Korean biotech firms attract major investments amid rising stock prices and government support - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFB0dXJUM0FTeVlna3BtbmRPNHVVb3RfeTNMOV9uVFIwbHVoS2M4bTZTdHJNQVFMbkVCbmN3aUR4cFFmczVhejRUdVZGNm1vV01CUVF5ZWpOaw?oc=5","date":"2021-04-12","type":"pipeline","source":"바이오스펙테이터","summary":"2 Key words of Txinno Bio..“Orally available STING agonist & RAS combination” - 바이오스펙테이터","headline":"2 Key words of Txinno Bio..“Orally available STING agonist & RAS combination” - 바이오스펙테이터","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}